Pasithea Financial Statements From 2010 to 2024

KTTAW Stock  USD 0.02  0  11.11%   
Pasithea Therapeutics financial statements provide useful quarterly and yearly information to potential Pasithea Therapeutics Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Pasithea Therapeutics financial statements helps investors assess Pasithea Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Pasithea Therapeutics' valuation are summarized below:
Revenue
486.6 K
Revenue Per Share
0.37
There are over seventy-six available trending fundamental ratios for Pasithea Therapeutics, which can be analyzed over time and compared to other ratios. All traders should should check out Pasithea Therapeutics' recent fundamental trends against the trends from 2010 to 2024 to make sure the company is sustainable. Market Cap is likely to drop to about 17.7 M in 2024. Enterprise Value is likely to climb to about (17.5 M) in 2024

Pasithea Therapeutics Total Revenue

362,332

Check Pasithea Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pasithea Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 680.9 K, Other Operating Expenses of 9.9 M or Total Operating Expenses of 9.8 M, as well as many indicators such as Price To Sales Ratio of 36.39, Dividend Yield of 0.0 or PTB Ratio of 0.38. Pasithea financial statements analysis is a perfect complement when working with Pasithea Therapeutics Valuation or Volatility modules.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Pasithea Therapeutics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets34.3 M26.1 M10.8 M
Slightly volatile
Other Current Liabilities2.7 M2.6 M399.2 K
Slightly volatile
Total Current Liabilities1.4 M2.6 M426.5 K
Slightly volatile
Total Stockholder Equity32.3 M23.4 M10.2 M
Slightly volatile
Accounts Payable2.7 M2.6 M482.2 K
Slightly volatile
Cash28.2 M16.3 M8.9 M
Slightly volatile
Cash And Short Term Investments28.2 M16.3 M8.9 M
Slightly volatile
Common Stock Shares Outstanding1.2 M1.2 M827.2 K
Slightly volatile
Liabilities And Stockholders Equity34.3 M26.1 M10.8 M
Slightly volatile
Other Current Assets464.2 K361.1 K146.4 K
Slightly volatile
Other Stockholder Equity48 M58.7 M15 M
Slightly volatile
Total LiabilitiesM2.7 M625.5 K
Slightly volatile
Net Invested Capital32.3 M23.4 M10.2 M
Slightly volatile
Total Current Assets28.7 M16.7 MM
Slightly volatile
Capital Stock98.810413.3 K
Slightly volatile
Net Working Capital27.3 M14.1 M8.6 M
Slightly volatile
Common Stock98.810413.3 K
Slightly volatile
Property Plant And Equipment Gross231.8 K244 K134.5 K
Slightly volatile
Short and Long Term Debt Total77.6 K81.7 K813.9 K
Slightly volatile
Net Receivables38.5 K40.5 K267.1 K
Slightly volatile
Short Term Debt96.8 K81.7 K150.9 K
Slightly volatile
Intangible Assets6.6 M7.9 M8.4 M
Slightly volatile
Other Assets0.80.90.98
Slightly volatile

Pasithea Therapeutics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization680.9 K648.5 K134.1 K
Slightly volatile
Other Operating Expenses9.9 M16 M3.1 M
Slightly volatile
Total Operating Expenses9.8 M16 M3.1 M
Slightly volatile
Interest Expense87.2191.8425
Slightly volatile
Selling General Administrative8.3 B7.9 B1.1 B
Slightly volatile
Total Revenue362.3 K559.5 K105.9 K
Slightly volatile
Cost Of Revenue680.9 K648.5 K110 K
Slightly volatile
Reconciled Depreciation543.5 K517.7 K74 K
Slightly volatile
Selling And Marketing Expenses4.3 B7.9 B815.7 M
Slightly volatile

Pasithea Therapeutics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash Flow28.2 M16.3 M8.9 M
Slightly volatile
Stock Based Compensation696.1 K592.3 K518.6 K
Slightly volatile
Begin Period Cash Flow31.6 M33.1 MM
Slightly volatile
Depreciation680.9 K648.5 K91.9 K
Slightly volatile
Issuance Of Capital Stock31 M24.4 M45.7 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio36.3938.312.2 K
Slightly volatile
PTB Ratio0.380.3991149
Slightly volatile
Book Value Per Share19.4518.54088.0139
Slightly volatile
Average Payables2.1 MM521.5 K
Slightly volatile
Stock Based Compensation To Revenue1.881.9725.401
Slightly volatile
Capex To Depreciation1.0E-41.0E-416.8785
Very volatile
PB Ratio0.380.3991149
Slightly volatile
Days Of Inventory On Hand0.00260.00290.0032
Slightly volatile
Payables Turnover0.270.25410.0709
Slightly volatile
Sales General And Administrative To Revenue16.3218.3619.988
Slightly volatile
Average Inventory0.40.450.49
Slightly volatile
Research And Ddevelopement To Revenue4.384.935.3684
Slightly volatile
Capex To Revenue2.333.961.8545
Slightly volatile
Cash Per Share17.1212.94067.0834
Slightly volatile
Days Payables Outstanding1.4 K1.4 K8.1 K
Slightly volatile
Income Quality8.0E-49.0E-40.8594
Slightly volatile
Intangibles To Total Assets0.230.35240.2278
Slightly volatile
Net Debt To EBITDA1.011.05999.7124
Slightly volatile
Current Ratio6.026.337137.5165
Pretty Stable
Tangible Book Value Per Share16.4311.24746.8061
Slightly volatile
Graham Number41.0972.638116.8913
Slightly volatile
Shareholders Equity Per Share19.4518.54088.0139
Slightly volatile
Capex Per Share0.00.00.1279
Slightly volatile
Graham Net Net15.9310.78666.6017
Slightly volatile
Revenue Per Share0.360.350.0835
Slightly volatile
Interest Debt Per Share1.0E-41.0E-44.0E-4
Slightly volatile
Enterprise Value Over EBITDA0.430.45082.317
Slightly volatile
Price Book Value Ratio0.380.3991149
Slightly volatile
Days Of Payables Outstanding1.4 K1.4 K8.1 K
Slightly volatile
Ebt Per Ebit0.680.97050.9383
Slightly volatile
Company Equity Multiplier0.851.11621.0245
Pretty Stable
Quick Ratio6.026.337137.5165
Pretty Stable
Net Income Per E B T0.791.02930.9839
Slightly volatile
Cash Ratio5.896.236.9375
Very volatile
Days Of Inventory Outstanding0.00260.00290.0032
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.1 KK138
Slightly volatile
Price To Book Ratio0.380.3991149
Slightly volatile
Fixed Asset Turnover0.630.450.6967
Slightly volatile
Enterprise Value Multiple0.430.45082.317
Slightly volatile
Price Sales Ratio36.3938.312.2 K
Slightly volatile
Asset Turnover0.01020.00970.0023
Slightly volatile
Price Fair Value0.380.3991149
Slightly volatile
Operating Cycle0.00260.00290.0032
Slightly volatile

Pasithea Therapeutics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap17.7 M18.6 M42.2 M
Slightly volatile

Pasithea Fundamental Market Drivers

Cash And Short Term Investments16.3 M

About Pasithea Therapeutics Financial Statements

Pasithea Therapeutics investors use historical fundamental indicators, such as Pasithea Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pasithea Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-2.6 M-2.7 M
Total Revenue559.5 K362.3 K
Cost Of Revenue648.5 K680.9 K
Stock Based Compensation To Revenue 1.97  1.88 
Sales General And Administrative To Revenue 18.36  16.32 
Research And Ddevelopement To Revenue 4.93  4.38 
Capex To Revenue 3.96  2.33 
Revenue Per Share 0.35  0.36 
Ebit Per Revenue(27.41)(28.78)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pasithea Stock Analysis

When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.